Comment on the paper "Cost-effectiveness of sofosbuvir in hepatitis C genotype 1 infection in Germany: A reanalysis of published results"

About the Authors: Axel C. Mühlbacher Roles Conceptualization, Methodology, Project administration, Writing – original draft, Writing – review & editing * E-mail: muehlbacher@hs-nb.de Affiliations Health Economics and Health Care Management, Hochschule Neubrandenburg, Neubrandenburg, Germany, Ge...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	PloS one 2021-02, Vol.16 (2), p.e0245480-e0245480
Hauptverfasser:	Mühlbacher, Axel C, Sadler, Andrew
Format:	Artikel
Sprache:	eng
Schlagworte:	Analysis Antiviral drugs Decision analysis Drug therapy Economics Editing Efficiency Engineering and Technology Formal Comment Genotypes Health care Health economics Health risks Hepatitis Hepatitis C Indicators Medical care, Cost of Medical ethics Medicine and health sciences Multiple criterion Performance measurement Preferences Research and Analysis Methods Science Policy Social Sciences Uncertainty analysis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!